I happen to agree with the dissenting view that was issued back in last November of 2020, and I think the empirical evidence bears that out with a market that is highly concentrated and an American public that is paying higher prices for pharmaceutical drugs than any other Western country.
Neguse criticizes the FTC's approach to pharmaceutical mergers and highlights rising drug prices.
Share
More from Joe Neguse
I am prepared to close, and I reserve the balance of my time. The SPEAKER pro tempore. Members are reminded to direct their remarks to the Chair.
Mr. Scott, if that is the case, and if you feel so passionate about the funding allocations in this bill, then why will the bill be held hostage the moment it passes this Chamber? If this bill passes the House tomorrow, Mr. Scott, when…
On that I demand the yeas and nays. The yeas and nays were ordered. The SPEAKER pro tempore. This is a 5-minute vote. The vote was taken by electronic device, and there were--yeas 245, nays 155, not voting 32, as follows: [Roll No. 462]…
Don't let anyone -- don't let anyone tell you that the American dream is dead.
Other voices in this conversation
